Our patented platform catheter technology could address multiple markets including peripheral bypass procedures, structural heart, and coronary applications.

Pathfinder line sail repeat pattern

Current Market Opportunities

CTO Re-entry
device

£108m

2020

Minimally invasive
bypass

£854m

2020

Minimally invasive 

AVF creation

£2.9b

2020

The ePATH platform catheter technology could address multiple markets including peripheral and coronary bypass procedures, structural heart, and endovascular aneurysm repair.

Pathfinder Medical-logo

Unit 12, baltimore house, Juniper Dr, London SW18 1TS, United Kingdom

Not available for sale in the United States © 2023 Stent Tek Ltd

Pathfinder Medical is the trading name of Stent Tek Ltd. Company No. 09289469

Accreditation logos